rs397516864
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM5
The NM_003673.4(TCAP):c.473G>A(p.Arg158His) variant causes a missense change. The variant allele was found at a frequency of 0.00000749 in 1,602,042 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R158C) has been classified as Uncertain significance.
Frequency
Consequence
NM_003673.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TCAP | NM_003673.4 | c.473G>A | p.Arg158His | missense_variant | 2/2 | ENST00000309889.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TCAP | ENST00000309889.3 | c.473G>A | p.Arg158His | missense_variant | 2/2 | 1 | NM_003673.4 | P1 | |
TCAP | ENST00000578283.1 | c.401G>A | p.Arg134His | missense_variant | 3/3 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.0000197 AC: 3AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000828 AC: 2AN: 241542Hom.: 0 AF XY: 0.00000760 AC XY: 1AN XY: 131614
GnomAD4 exome AF: 0.00000621 AC: 9AN: 1449862Hom.: 0 Cov.: 34 AF XY: 0.00000416 AC XY: 3AN XY: 721654
GnomAD4 genome ? AF: 0.0000197 AC: 3AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 13, 2012 | The Arg158His variant (TCAP) has not been previously reported but has been ident ified by our laboratory in 1 individual with a family history of sudden death of unknown etiology. Computational analyses (biochemical amino acid properties, co nservation, AlignGVGD, PolyPhen2, and SIFT) suggest that this variant may impact the protein, though this information is not predictive enough to determine path ogenicity. Of note, a different variant at the same position (Arg158Ser, unknown significance) has been detected by our laboratory in an individual with DCM. A dditional information is needed to fully assess the clinical significance of the Arg158His variant. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 03, 2021 | The p.R158H variant (also known as c.473G>A), located in coding exon 2 of the TCAP gene, results from a G to A substitution at nucleotide position 473. The arginine at codon 158 is replaced by histidine, an amino acid with highly similar properties. Other alterations affecting this amino acid (p.R158C, c.472C>T and p.R158S, c.472C>A) have been detected in dilated cardiomyopathy cohorts; however, clinical details were limited (Hirtle-Lewis M et al. Clin Cardiol. 2013;36:628-33; Akinrinade O et al. Eur Heart J. 2015;36:2327-37). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Primary familial hypertrophic cardiomyopathy;C4225408:Hypertrophic cardiomyopathy 25 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Mar 27, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Arg158 amino acid residue in TCAP. Other variant(s) that disrupt this residue have been observed in individuals with TCAP-related conditions (Invitae), which suggests that this may be a clinically significant amino acid residue. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 44712). This variant has not been reported in the literature in individuals affected with TCAP-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 158 of the TCAP protein (p.Arg158His). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at